20 Participants Needed

Hearing Rehabilitation for Cognitive Impairment

CL
RC
JT
Overseen ByJami Trumbo, MSPH
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Johns Hopkins University

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to develop and test a hearing rehabilitation program specifically for individuals with cognitive impairment, such as Alzheimer's, using a new device and program called HEARS-SLP. The study will evaluate the effectiveness of this treatment when delivered by a speech-language pathologist. Participants will either begin the treatment immediately or after a one-month delay for comparison. Ideal participants are English-speaking individuals who live at home, have been diagnosed with Alzheimer's or related dementia, experience hearing loss, and have a caregiver who assists them regularly. As an unphased trial, this study provides a unique opportunity to contribute to innovative research in hearing rehabilitation for cognitive impairment.

Will I have to stop taking my current medications?

The trial requires that your medication dosage for neuropsychiatric symptoms be stable for at least 2 weeks, so you may not need to stop taking your current medications if they meet this condition.

What prior data suggests that the HEARS-SLP device and program are safe for individuals with cognitive impairment?

Research shows that specific safety information for the HEARS-SLP device or program is not yet available. Detailed studies have not yet determined its safety for individuals. The trial is in an early stage, so researchers are still assessing how participants might respond to the treatment. Early trials typically focus on evaluating a treatment's effectiveness and identifying any side effects. Those concerned about the treatment's safety should consult their doctor before deciding to join the trial.12345

Why are researchers excited about this trial?

Researchers are excited about the HEARS-SLP device and program because they offer a fresh approach to addressing cognitive impairment linked to hearing loss. Unlike traditional hearing aids that simply amplify sound, the HEARS-SLP system combines an innovative device with a specialized program to potentially enhance cognitive functions by improving auditory processing. This dual approach targets not only the hearing issues but also aims to directly boost cognitive health, which could be a game-changer compared to existing treatments that primarily focus on hearing improvement alone.

What evidence suggests that the HEARS-SLP device and program are effective for hearing rehabilitation in individuals with cognitive impairment?

Research shows that the HEARS-SLP treatment, which uses a device and a program, is specifically designed to address hearing and thinking problems. In this trial, participants will join either an immediate treatment arm or a delayed treatment arm. Previous studies on the HEARS model have shown that community-based programs can effectively support hearing health. By involving speech-language pathologists (SLPs) in delivering this treatment, the program aims to make hearing help more accessible and affordable. Early results suggest that using SLPs could enhance the program's effectiveness for individuals with thinking difficulties. This approach is expected to improve communication and overall quality of life for participants.12345

Who Is on the Research Team?

EO

Esther Oh, MD, PhD

Principal Investigator

Johns Hopkins School of Medicine

Are You a Good Fit for This Trial?

This trial is for English-speaking individuals aged 60-100 with probable Alzheimer's or related dementia, who live at home and have stable medication dosing. They must have adult-onset hearing loss and a caregiver available to assist with the study.

Inclusion Criteria

You have an average speech frequency pure tone greater than 25 decibels in your better-hearing ear and suffer from adult onset hearing loss.
You have a caregiver/study partner who is available to attend all study-related visits and can provide at least 8 hours of weekly supervision.
I have been diagnosed with Alzheimer's Disease or a similar type of dementia.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Immediate Treatment

Participants receive immediate hearing rehabilitative intervention delivered by a speech-language pathologist

1 month
4 visits (in-person)

Delayed Treatment

Participants receive delayed hearing rehabilitative intervention delivered by a speech-language pathologist after a 1-month delay

1 month
4 visits (in-person)

Follow-up

Participants are monitored for changes in neuropsychiatric symptoms and quality of life post-intervention

1 month

What Are the Treatments Tested in This Trial?

Interventions

  • HEARS-SLP device
  • HEARS-SLP program
Trial Overview The HEARS-SLP program and device are being tested to see if they can help people with cognitive impairment by providing affordable hearing care through speech-language pathologists.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Immediate treatmentExperimental Treatment2 Interventions
Group II: Delayed treatmentPlacebo Group2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Johns Hopkins University

Lead Sponsor

Trials
2,366
Recruited
15,160,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Published Research Related to This Trial

Despite the potential benefits of auditory training programs for individuals with hearing loss, fewer than 10% of audiologists currently offer these services, which can help reduce the rate of hearing aid returns.
Compliance with home-based auditory training is low, with less than 30% of patients completing the programs, highlighting the need for strategies to improve patient engagement and adherence to therapy.
Auditory training and challenges associated with participation and compliance.Sweetow, RW., Sabes, JH.[2022]
Aging negatively impacts how the brain processes sensory information, particularly in hearing, which can increase the cognitive effort required to understand sounds.
Audiologic rehabilitation techniques, such as hearing aids and listening training, can help reduce the cognitive load needed for effective communication, making it easier for older adults to process auditory signals.
Listening and Learning: Cognitive Contributions to the Rehabilitation of Older Adults With and Without Audiometrically Defined Hearing Loss.Tremblay, KL., Backer, KC.[2018]
Hearing aids alone do not fully address hearing loss, and many adults still experience low satisfaction and performance, especially in noisy environments, despite advancements in technology.
Auditory training can enhance speech recognition and satisfaction with hearing devices, suggesting that combining technology with training may lead to better outcomes for individuals with hearing loss.
Options for Auditory Training for Adults with Hearing Loss.Olson, AD.[2022]

Citations

Providing SLP-Delivered Hearing Health Care to ...Building upon the HEARS audiologist-community health worker (CHW) model, this study intervention will be delivered by a speech-language pathologist (SLP). The ...
Hearing Rehabilitation for Cognitive ImpairmentThe HEARS-SLP treatment is unique because it combines a device and a program specifically designed to address both hearing and cognitive challenges, unlike ...
Providing SLP-Delivered Hearing Health Care to ...The primary objective of the study is to develop and test an affordable and accessible hearing rehabilitative intervention that will be delivered by a SLP to ...
Providing SLP-Delivered Hearing Health Care to...The primary objective of the study is to develop and test an affordable and accessible hearing rehabilitative intervention that will be ...
The Baltimore HEARS Pilot Study (NCT02045511)The primary purpose of the study is to develop and test the preliminary efficacy of a first-in-kind community-based intervention to provide affordable, ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security